ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.630
+0.230 (16.43%)
At close: Nov 4, 2024, 4:00 PM
1.570
-0.060 (-3.68%)
After-hours: Nov 4, 2024, 7:59 PM EST
ESSA Pharma Employees
ESSA Pharma had 50 employees as of September 30, 2023. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$553,379
Market Cap
72.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
TELA Bio | 227 |
Xtant Medical Holdings | 215 |
Hyperfine | 131 |
Spero Therapeutics | 46 |
Vivani Medical | 44 |
Modular Medical | 40 |
Zentek | 24 |
Cellectar Biosciences | 20 |
EPIX News
- 17 hours ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Investors to Connect - Accesswire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Stockholders to Connect - Accesswire
- 3 days ago - ESSA Pharma Inc. (EPIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 days ago - ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer - PRNewsWire
- 7 weeks ago - ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress - PRNewsWire
- 7 weeks ago - ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference - PRNewsWire
- 3 months ago - ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024 - PRNewsWire
- 4 months ago - ESSA Pharma to Present at the JonesHealthcare Seaside Summit - PRNewsWire